Avita Medical | مبيعات



Sales تغيير تاريخ
Adcock Ingram Holdings ZAR 4.71B 188.47M 2024-12
Celltrion KRW 961.51B 119.6B 2025-06
Clinuvel Pharmaceuticals AUD 55.92M 23.66M 2024-06
Cochlear AUD 1.17B 34.7M 2024-12
CSL USD 8.21B 1.47B 2024-12
Cspc Pharmaceutical CNY 7.01B 691.61M 2025-03
Dianthus Therapeutics USD 193K 1.13M 2025-06
Divis Laboratories Ltd 24.1B 1.75B 2025-06
Kangmei Pharma CNY 1.27B 32.4M 2025-06
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma 159.7M 274.71M 2025-06
Malin Corporation EUR 19.2M 2.6M 2020-12
Mayne Pharma AUD 195.04M 5.43M 2025-06
Medical Developments International AUD 7.54M 0 2023-12
Nanosonics AUD 93.6M 48.4M 2024-12
Neuren Pharmaceuticals AUD 194.1M 163.93M 2024-12
Organigram Holdings CAD 70.79M 28.06M 2025-06
Pacific Edge NZD 10.96M 5.32M 2024-09
Paradigm Biopharmaceuticals AUD 433.66K 4.81M 2024-12
Pharma Mar EUR 56.39M 17.49M 2025-06
Polynovo AUD 34.58M 24.94M 2025-06
PYC Therapeutics AUD 12.69M 6.11M 2024-12
Qiagen NV USD 533.54M 108.24M 2025-06
Ramsay Health Care AUD 9.29B 700M 2025-12
ResMed USD 1.35B 65.9M 2025-06
Sartorius EUR 884.3M 1.3M 2025-06
Sino Biopharmaceutical CNY 17.57B 1.7B 2025-06
Telix Pharmaceuticals AUD 309.72M 109.32M 2025-06
Tilray USD 308.01M 43.78M 2025-06
Zhangzhou Pientzehuang Pharmaceutical 2.24B 902.99M 2025-06


Avita Medical مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Sep 2025.